Anton W. Fetting

Array ( [id] => 3734091 [patent_doc_number] => 05698431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Herpes simplex virus mutant UL41NHB' [patent_app_type] => 1 [patent_app_number] => 8/385942 [patent_app_country] => US [patent_app_date] => 1995-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 19 [patent_no_of_words] => 8262 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698431.pdf [firstpage_image] =>[orig_patent_app_number] => 385942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868852 [patent_doc_number] => 05763242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Method for increasing transduction efficiency of recombinant retroviral vectors' [patent_app_type] => 1 [patent_app_number] => 8/385446 [patent_app_country] => US [patent_app_date] => 1995-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3776 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763242.pdf [firstpage_image] =>[orig_patent_app_number] => 385446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874295 [patent_doc_number] => 05747308 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Recombinant DNA method' [patent_app_type] => 1 [patent_app_number] => 8/385063 [patent_app_country] => US [patent_app_date] => 1995-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6226 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747308.pdf [firstpage_image] =>[orig_patent_app_number] => 385063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3866667 [patent_doc_number] => 05837528 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Bacterial strains which overproduce riboflavin' [patent_app_type] => 1 [patent_app_number] => 8/384626 [patent_app_country] => US [patent_app_date] => 1995-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21433 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837528.pdf [firstpage_image] =>[orig_patent_app_number] => 384626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655907 [patent_doc_number] => 05658775 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Double copy retroviral vector' [patent_app_type] => 1 [patent_app_number] => 8/380935 [patent_app_country] => US [patent_app_date] => 1995-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11473 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658775.pdf [firstpage_image] =>[orig_patent_app_number] => 380935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4005106 [patent_doc_number] => 05888764 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Human fas gene promoter region' [patent_app_type] => 1 [patent_app_number] => 8/377522 [patent_app_country] => US [patent_app_date] => 1995-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 25443 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888764.pdf [firstpage_image] =>[orig_patent_app_number] => 377522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811677 [patent_doc_number] => 05710015 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'cDNA cloning of inositol monophosphatase' [patent_app_type] => 1 [patent_app_number] => 8/347471 [patent_app_country] => US [patent_app_date] => 1995-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4372 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710015.pdf [firstpage_image] =>[orig_patent_app_number] => 347471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730433 [patent_doc_number] => 05665592 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Feline immunodeficiency virus isolate NCSU.sub.1' [patent_app_type] => 1 [patent_app_number] => 8/365901 [patent_app_country] => US [patent_app_date] => 1994-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 11378 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665592.pdf [firstpage_image] =>[orig_patent_app_number] => 365901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773046 [patent_doc_number] => 05817491 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'VSV G pseusdotyped retroviral vectors' [patent_app_type] => 1 [patent_app_number] => 8/361839 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13610 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817491.pdf [firstpage_image] =>[orig_patent_app_number] => 361839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3953884 [patent_doc_number] => 05935810 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Mammalian ob polypeptides capable of modulating body weight, corresponding nucleic acids, and diagnostic and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/347563 [patent_app_country] => US [patent_app_date] => 1994-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 38 [patent_no_of_words] => 31492 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935810.pdf [firstpage_image] =>[orig_patent_app_number] => 347563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727547 [patent_doc_number] => 05652130 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Retroviral vectors expressing tumor necrosis factor (TNF)' [patent_app_type] => 1 [patent_app_number] => 8/346361 [patent_app_country] => US [patent_app_date] => 1994-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6834 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652130.pdf [firstpage_image] =>[orig_patent_app_number] => 346361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936874 [patent_doc_number] => 05871958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Mutant rev genes encoding transdominant repressors of HIV replication' [patent_app_type] => 1 [patent_app_number] => 8/333703 [patent_app_country] => US [patent_app_date] => 1994-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 20851 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871958.pdf [firstpage_image] =>[orig_patent_app_number] => 333703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805141 [patent_doc_number] => 05854038 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Localization of a therapeutic agent in a cell in vitro' [patent_app_type] => 1 [patent_app_number] => 8/324362 [patent_app_country] => US [patent_app_date] => 1994-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 7487 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854038.pdf [firstpage_image] =>[orig_patent_app_number] => 324362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3528844 [patent_doc_number] => 05583022 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Defective recombinant retrovirus' [patent_app_type] => 1 [patent_app_number] => 8/298181 [patent_app_country] => US [patent_app_date] => 1994-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5179 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583022.pdf [firstpage_image] =>[orig_patent_app_number] => 298181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759388 [patent_doc_number] => 05741666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Compositions and methods, for the treatment of body weight disorders, including obesity' [patent_app_type] => 1 [patent_app_number] => 8/294522 [patent_app_country] => US [patent_app_date] => 1994-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 22 [patent_no_of_words] => 33679 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741666.pdf [firstpage_image] =>[orig_patent_app_number] => 294522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686270 [patent_doc_number] => 05643770 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Retroviral vector particles expressing complement inhibitor activity' [patent_app_type] => 1 [patent_app_number] => 8/278630 [patent_app_country] => US [patent_app_date] => 1994-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15926 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643770.pdf [firstpage_image] =>[orig_patent_app_number] => 278630 [rel_patent_id] =>[rel_patent_doc_number] =>)